Stockreport

Shareholders in Travere Therapeutics (NASDAQ:TVTX) are in the red if they invested five years ago [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF But that can't change the reality that over the longer term (five years), the returns have been really quite dismal. Indeed, the share price is down 64% in the period. S [Read more]